- Home
- PRKS vs RXRX Comparison
PRKS vs RXRX Comparison
Compare PRKS & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRKS | RXRX |
|---|---|---|
| Founded | 1959 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.2B |
| IPO Year | 2012 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PRKS | RXRX |
|---|---|---|
| Price | $31.49 | $4.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 7 |
| Target Price | ★ $45.80 | $7.32 |
| AVG Volume (30 Days) | 610.5K | ★ 24.8M |
| Earning Date | 11-05-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.79 |
| EPS | ★ 0.60 | N/A |
| Revenue | ★ $1,263,324,000.00 | $74,681,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.89 | $26.91 |
| P/E Ratio | $51.15 | ★ N/A |
| Revenue Growth | N/A | ★ 26.92 |
| 52 Week Low | $28.77 | $2.77 |
| 52 Week High | $50.17 | $6.10 |
Technical Indicators
Market Signals| Indicator | PRKS | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 40.73 | 55.72 |
| Support Level | $29.43 | $2.90 |
| Resistance Level | $34.15 | $5.22 |
| Average True Range (ATR) | 1.52 | 0.37 |
| MACD | 0.10 | -0.02 |
| Stochastic Oscillator | 37.87 | 68.18 |
Price Performance
Historical ComparisonAbout PRKS United Parks & Resorts Inc.
United Parks & Resorts Inc is an American theme park and entertainment company. Its core business is the operation of theme parks and entertainment facilities involving sea animals across the country under prominent brands such as SeaWorld, Busch Gardens, Aquatica, Discovery Cove, and Sesame Place. The company generates the majority of its revenue from selling admission tickets for its theme parks.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.